413 filings
Page 2 of 21
8-K
31y7v5sjn2
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
vbn3vqlrve
7 Dec 23
Kintara Therapeutics Announces Review of Strategic Alternatives
9:10am
8-K
0hi7k6sb5
5 Dec 23
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement
9:10am
8-K
7c3d4xn2sw7eyddkk23
21 Nov 23
Departure of Directors or Certain Officers
7:55am
8-K
ojjxe1r5hz l5eq
13 Nov 23
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update
4:15pm
8-K
o38krmaki
31 Oct 23
Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study
8:10am
8-K
3wkzhul
10 Oct 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
ud0 amjdvjq34
26 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:09pm
8-K
nwg6u3yaj4ngafq bfz
19 Sep 23
Entry into a Material Definitive Agreement
4:20pm
424B5
xtf 46k67f5
19 Sep 23
Prospectus supplement for primary offering
4:16pm
8-K
wfziv2mtp97
18 Sep 23
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update
4:31pm
8-K
hn93fjawxvj4 wfq
30 Jun 23
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
96rvj6 dhn5lak5r
15 Jun 23
Submission of Matters to a Vote of Security Holders
3:31pm